- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Neuraxis is a biotechnology business based in the US. Neuraxis shares (NRXS) are listed on the NYSE MKT and all prices are listed in US Dollars. Its last market close was $2.57 – a decrease of 0.39% over the previous week. Neuraxis employs 19 staff and has a trailing 12-month revenue of around $2.3 million.
Our top picks for where to buy Neuraxis stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Neuraxis stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – NRXS. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Neuraxis stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Neuraxis stock price (NYSE MKT: NRXS)
Use our graph to track the performance of NRXS stocks over time.Neuraxis shares at a glance
Information last updated 2024-12-12.
| Latest market close | $2.57 |
|---|---|
| 52-week range | $2.00 - $3.89 |
| 50-day moving average | $2.91 |
| 200-day moving average | $3.05 |
| Wall St. target price | $7.50 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.40 |
Is it a good time to buy Neuraxis stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Neuraxis price performance over time
Historical closes compared with the close of $2.51 from 2024-12-16
| 1 week (2024-12-11) | -2.71% |
|---|---|
| 1 month (2024-11-19) | -22.77% |
| 3 months (2024-09-18) | -14.04% |
| 6 months (2024-06-18) | -10.36% |
| 1 year (2023-12-18) | 14.09% |
|---|---|
| 2 years (2022-12-15) | N/A |
| 3 years (2021-12-15) | N/A |
| 5 years (2019-12-15) | N/A |
Neuraxis financials
| Revenue TTM | $2.3 million |
|---|---|
| Gross profit TTM | $0 |
| Return on assets TTM | -260.29% |
| Return on equity TTM | 0% |
| Profit margin | 0% |
| Book value | $-0.22 |
| Market Capitalization | $18 million |
TTM: trailing 12 months
Neuraxis share dividends
We're not expecting Neuraxis to pay a dividend over the next 12 months.
You may also wish to consider:
Neuraxis overview
NeurAxis, Inc. , a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022.
Frequently asked questions
nullWhat percentage of Neuraxis is owned by insiders or institutions?
Currently 53.181% of Neuraxis shares are held by insiders and 1.772% by institutions. How many people work for Neuraxis?
Latest data suggests 19 work at Neuraxis. When does the fiscal year end for Neuraxis?
Neuraxis's fiscal year ends in December. Where is Neuraxis based?
Neuraxis's address is: 11611 North Meridian Street, Carmel, IN, United States, 46032
More resources on Finder
More guides on Finder
-
CashUSA: Fast But Flawed Loan Connection Up to $10K
A review of CashUSA, a loan connection service that may match you with lenders offering loans up to $10,000.
-
How to Earn Money Playing Games
Explore different ways you could earn money playing games with GPT apps, Twitch streaming, esports competitions, and trading cards.
-
Highest Paying Online Surveys
Compare highly rated and legit survey sites for your next side hustle, how to maximize your survey earnings, and how to avoid scams.
-
How to Earn Money Through User Testing
Learn how to become user tester, how much you can earn, top platforms for user testing, and how to avoid scams.
-
How to Earn Money Through Surveys
Learn how to earn money through trusted online surveys, including top platforms, practical tips, and some red flags to watch out for.
-
Online Surveys for Money
Earning extra cash can be as simple as sharing your thoughts. In this guide, we’ll walk you through some of the most trusted survey sites and show you how to get started right away.
-
Cash Advance Loans by Amount
Cash Advance loans by amount from $100 all the way up to $1,000 USD.
-
Investing After Retirement
Bonds, treasury securities, blue chip stocks, ETFs, REITs, CDs and annuities are some of the best investments for retirees.
-
Alternatives to GoHenry (Now Acorns Early)
GoHenry is now Acorns Early. If you’re looking for a GoHenry alternative, try Greenlight, Step, Current, Modak Makers or Chase First.
-
Apps Like Self
Top apps like Self that build credit include Kikoff, Grow Credit, Chime Secured Credit Builder Card, Credit Strong and Cleo.